Novavax, Inc.
NVAX
$10.64
$0.565.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 440.30M | 341.75M | 422.82M | 478.70M | -187.50M |
| Total Depreciation and Amortization | 27.61M | 35.01M | 41.12M | 44.69M | 48.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 175.16M | 107.58M | -13.94M | 12.79M | 3.26M |
| Change in Net Operating Assets | -887.71M | -862.65M | -1.08B | -725.38M | 48.48M |
| Cash from Operations | -244.64M | -378.32M | -630.94M | -189.21M | -87.26M |
| Capital Expenditure | -5.56M | -5.42M | -4.77M | -7.40M | -13.06M |
| Sale of Property, Plant, and Equipment | -- | 192.64M | 192.64M | 192.64M | 192.64M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.71M | -141.97M | 25.83M | -455.35M | -383.62M |
| Cash from Investing | -78.27M | 45.26M | 213.70M | -270.11M | -204.04M |
| Total Debt Issued | 42.61M | 42.61M | -- | -- | -- |
| Total Debt Repaid | -10.07M | -6.55M | -6.08M | -5.84M | -3.99M |
| Issuance of Common Stock | 5.29M | 5.29M | 415.00K | 258.38M | 265.24M |
| Repurchase of Common Stock | -5.29M | -5.95M | -5.95M | -666.00K | -666.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.80M | -4.47M | 0.00 | -4.24M | 0.00 |
| Cash from Financing | 27.74M | 30.92M | -11.62M | 247.64M | 260.58M |
| Foreign Exchange rate Adjustments | 5.93M | -3.08M | 2.29M | -5.78M | -7.80M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -289.24M | -305.23M | -426.58M | -217.46M | -38.52M |